androstenedione has been researched along with Meningioma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carsol, JL; Délos, S; Ghazarossian, E; Martin, PM; Raynaud, JP | 1 |
| Grunberg, S; Heikinheimo, O; Lähteenmäki, P; Ranta, S; Spitz, IM | 1 |
| de Jong, FH; Koper, JW; Lamberts, SW | 1 |
3 other study(ies) available for androstenedione and Meningioma
| Article | Year |
|---|---|
Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts.
Topics: 17-Hydroxysteroid Dehydrogenases; Adenosarcoma; Androstenedione; Azasteroids; Blotting, Northern; Cells, Cultured; Cholestenone 5 alpha-Reductase; Chromatography, High Pressure Liquid; Dihydrotestosterone; Enzyme Inhibitors; Epithelium; Etiocholanolone; Fibroblasts; Finasteride; Humans; Male; Meningioma; Oxidoreductases; Placenta; Prostatic Neoplasms; RNA; RNA, Messenger; Testosterone; Tumor Cells, Cultured | 1995 |
Alterations in the pituitary-thyroid and pituitary-adrenal axes--consequences of long-term mifepristone treatment.
Topics: Administration, Oral; Androstenedione; Female; Hormone Antagonists; Humans; Hydrocortisone; Male; Meningioma; Mifepristone; Pituitary-Adrenal System; Prolactin; Thyroid Gland; Thyrotropin; Thyroxine; Time Factors; Triiodothyronine | 1997 |
The endocrine effects of long-term treatment with mifepristone (RU 486).
Topics: Adrenocorticotropic Hormone; Adult; Aged; Androgens; Androstenedione; Brain Neoplasms; Circadian Rhythm; Corticotropin-Releasing Hormone; Dexamethasone; Estradiol; Estrogens; Female; Humans; Hydrocortisone; Male; Meningioma; Middle Aged; Mifepristone; Nausea; Vomiting | 1991 |